Eli Lilly wins FDA approval to launch a multi-dose KwikPen for its weight-loss drug Zepbound in the U.S.
Lilly to launch multi-dose weight-loss drug device in US
One America News Network
Feb 23, 2026 | 9:06 AM
Eli Lilly wins FDA approval to launch a multi-dose KwikPen for its weight-loss drug Zepbound in the U.S.